Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Increase (Decrease) in Employee Related Liabilities

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Increase (Decrease) in Employee Related Liabilities

VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Employee Related Liabilities of -$374.51 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-12

  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was -$95.88K.
  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$278.63K, a 509.62% decline year-over-year.
  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was -$33.12K, a 247.68% decline year-over-year.
  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was -$82.41K, a 270.68% decline year-over-year.
  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for fiscal 2025 was -$48.62K, a 124.56% decline from fiscal 2024.
  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for fiscal 2024 was $197.94K.
  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for fiscal 2020 was -$740.00K.
  • VYOME HOLDINGS, INC. increase (decrease) in employee related liabilities for fiscal 2019 was -$2.98M.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 12 month
2026-06-30-$95.88K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$374.51K
10-Q · filed 2026-08-12
-$407.63K
derived: sum of 3 quarters · filed 2026-08-12
-$490.04K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$278.63K
10-Q · filed 2026-05-12
-$311.75K
derived: sum of 2 quarters · filed 2026-05-12
-$394.16K
derived: sum of 3 quarters · filed 2026-05-12
-$395.27K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$33.12K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$115.53K
derived: sum of 2 quarters · filed 2026-03-18
-$116.64K
derived: sum of 3 quarters · filed 2026-08-12
-$48.62K
10-K · filed 2026-03-18
2025-09-30-$82.41K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$83.52K
derived: sum of 2 quarters · filed 2026-08-12
-$15.50K
10-Q · filed 2025-11-14
$6.92K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$1.11K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
$66.91K
10-Q · filed 2026-08-12
$89.34K
derived: sum of 3 quarters · filed 2026-08-12
$137.63K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$68.02K
10-Q · filed 2026-05-12
$90.45K
derived: sum of 2 quarters · filed 2026-05-12
$138.73K
derived: sum of 3 quarters · filed 2026-05-12
2024-12-31$22.43K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$70.71K
derived: sum of 2 quarters · filed 2026-03-18
$197.94K
10-K · filed 2026-03-18
2024-09-30$48.29K
derived: 10-Q 9 month − 8-K 6 month · filed 2025-11-14
$175.51K
10-Q · filed 2025-11-14
2024-06-30$127.22K
8-K · filed 2025-09-02
2021-03-31$537.00K
10-Q · filed 2021-05-12
$485.00K
derived: sum of 2 quarters · filed 2021-05-12
$361.00K
derived: sum of 3 quarters · filed 2021-05-12
$243.00K
derived: sum of 4 quarters · filed 2021-05-12
2020-12-31-$52.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$176.00K
derived: sum of 2 quarters · filed 2021-03-12
-$294.00K
derived: sum of 3 quarters · filed 2021-03-12
-$740.00K
10-K · filed 2021-03-12
2020-09-30-$124.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$242.00K
derived: sum of 2 quarters · filed 2020-11-06
-$688.00K
10-Q · filed 2020-11-06
-$576.00K
derived: sum of 4 quarters · filed 2021-05-12
2020-06-30-$118.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
-$564.00K
10-Q · filed 2020-07-30
-$452.00K
derived: sum of 3 quarters · filed 2021-05-12
-$837.00K
derived: sum of 4 quarters · filed 2021-05-12
2020-03-31-$446.00K
10-Q · filed 2021-05-12
-$334.00K
derived: sum of 2 quarters · filed 2021-05-12
-$719.00K
derived: sum of 3 quarters · filed 2021-05-12
-$612.00K
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$112.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$273.00K
derived: sum of 2 quarters · filed 2021-03-12
-$166.00K
derived: sum of 3 quarters · filed 2021-03-12
-$2.98M
10-K · filed 2021-03-12
2019-09-30-$385.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$278.00K
derived: sum of 2 quarters · filed 2020-11-06
-$3.10M
10-Q · filed 2020-11-06
-$1.96M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$107.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
-$2.71M
10-Q · filed 2020-07-30
-$1.58M
derived: sum of 3 quarters · filed 2020-07-30
-$1.04M
derived: sum of 4 quarters · filed 2020-07-30
2019-03-31-$2.82M
10-Q · filed 2020-06-19
-$1.69M
derived: sum of 2 quarters · filed 2020-06-19
-$1.15M
derived: sum of 3 quarters · filed 2020-06-19
-$845.00K
derived: sum of 4 quarters · filed 2020-06-19
2018-12-31$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$1.67M
derived: sum of 2 quarters · filed 2020-02-27
$1.97M
derived: sum of 3 quarters · filed 2020-02-27
-$689.00K
10-K · filed 2020-02-27
2018-09-30$539.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$840.00K
derived: sum of 2 quarters · filed 2019-11-08
-$1.82M
10-Q · filed 2019-11-08
$0.00
derived: sum of 4 quarters · filed 2019-11-08
2018-06-30$301.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
-$2.36M
10-Q · filed 2019-07-24
-$539.00K
derived: sum of 3 quarters · filed 2019-07-24
-$249.00K
derived: sum of 4 quarters · filed 2019-07-24
2018-03-31-$2.66M
10-Q · filed 2019-05-10
-$840.00K
derived: sum of 2 quarters · filed 2019-05-10
-$550.00K
derived: sum of 3 quarters · filed 2019-05-10
$276.00K
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$2.11M
derived: sum of 2 quarters · filed 2019-02-22
$2.94M
derived: sum of 3 quarters · filed 2019-02-22
$2.00M
10-K · filed 2019-02-22
2017-09-30$290.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$1.12M
derived: sum of 2 quarters · filed 2018-11-02
$174.00K
10-Q · filed 2018-11-02
$1.99M
derived: sum of 4 quarters · filed 2018-11-02
2017-06-30$826.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
-$116.00K
10-Q · filed 2018-08-02
$1.70M
derived: sum of 3 quarters · filed 2018-08-02
$2.15M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31-$942.00K
10-Q · filed 2018-05-10
$871.00K
derived: sum of 2 quarters · filed 2018-05-10
$1.32M
derived: sum of 3 quarters · filed 2018-05-10
$1.30M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$1.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$2.26M
derived: sum of 2 quarters · filed 2018-03-05
$2.25M
derived: sum of 3 quarters · filed 2018-03-05
$1.25M
10-K · filed 2018-03-05
2016-09-30$448.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$434.00K
derived: sum of 2 quarters · filed 2017-11-03
-$566.00K
10-Q · filed 2017-11-03
$485.00K
derived: sum of 4 quarters · filed 2018-03-05
2016-06-30-$14.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$1.01M
10-Q · filed 2017-08-02
$37.00K
derived: sum of 3 quarters · filed 2018-03-05
2016-03-31-$1.00M
10-Q · filed 2017-05-10
$51.00K
derived: sum of 2 quarters · filed 2018-03-05
2015-12-31$1.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$1.02M
10-K · filed 2018-03-05
2015-09-30-$33.00K
10-Q · filed 2016-11-10
2014-12-31$33.00K
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36